Calvin Sandra sold TVTX
April 14, 2026 · Form 4 insider transaction
Calvin Sandra sold 21,977 shares of Travere Therapeutics, Inc. at $41.07 per share, a transaction worth $902.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
21,977
Price
$41.07
Total value
$902.6K
InsiderCalvin Sandra
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 14, 2026
Filing dateApril 16, 2026
Shares owned after42,353
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on June 10, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.